Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.

Immunology
Else Marie AggerPeter Andersen

Abstract

It is known that protection against tuberculosis is mediated primarily by T helper type 1 (Th1) cells but the influence of the Th1/Th2 balance of a vaccination response on the subsequent protection and pathology during infection has not been studied in detail. We designed a panel of Ag85B-ESAT-6 subunit vaccines based on adjuvants with different Th1/Th2-promoting activities and studied cellular responses, bacterial replication and pathology in the lungs of mice infected with Mycobacterium tuberculosis. All vaccines induced cell-mediated and humoral responses but with markedly different interferon-gamma : interleukin-5 (IFN-gamma : IL-5) and immunoglobulin G1 (IgG1) : IgG2 ratios. The vaccines promoted different levels of control of bacterial replication with the most efficient protection being exerted by cationic liposomes containing monophosphoryl lipid A and low to completely absent immunity with conventional aluminium. The level of protection correlated with the amount of IFN-gamma produced in response to the vaccine whereas there was no inverse correlation with the level of IL-5. Characterizing a protective response was an accelerated recruitment of IL-17 and IFN-gamma-producing lymphocytes resulting in the early formation ...Continue Reading

References

Apr 1, 1991·Infection and Immunity·P AndersenI Heron
Dec 1, 1993·The Journal of Experimental Medicine·J L FlynnB R Bloom
Dec 1, 1993·The Journal of Experimental Medicine·A M CooperI M Orme
Dec 26, 1996·The New England Journal of Medicine·E JouanguyJ L Casanova
Feb 1, 1997·Infection and Immunity·E B LindbladP Andersen
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·J D MacMickingC F Nathan
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·E R RhoadesI M Orme
Nov 18, 1998·Immunology Today·R MartinD A Hafler
Jun 6, 2000·Advanced Drug Delivery Reviews·R K Gupta
Feb 28, 2001·Microbiology and Immunology·I SugawaraY Iwakura
Apr 17, 2001·The Journal of Experimental Medicine·G IezziA Lanzavecchia
May 11, 2002·Nature Reviews. Immunology·Susan M KaechRaft Ahmed
Sep 10, 2002·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Randy SaccoRichard G Lynch
Nov 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Robin StephensDavid D Chaplin
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Abebech DemissieUNKNOWN VACSEL Study Group
Jun 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yasir A W SkeikySteven G Reed
Sep 15, 2004·Transactions of the Royal Society of Tropical Medicine and Hygiene·Alison M ElliottJames A G Whitworth
Nov 20, 2004·The Journal of Infectious Diseases·T Mark DohertyPeter Andersen
May 10, 2005·Microbes and Infection·Peter Andersen, T Mark Doherty
Aug 23, 2005·Infection and Immunity·Ida RosenkrandsPeter Andersen
Oct 1, 2005·Respiration; International Review of Thoracic Diseases·Paweł RemiszewskiEwa Rowińska-Zakrzewska
Mar 21, 2006·Lancet·T Mark Doherty, Graham Rook
Apr 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Diane OrdwayMercedes Gonzalez-Juarrero

❮ Previous
Next ❯

Citations

Dec 8, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Madhan Kumar MurthyAlamelu Raja
Apr 25, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Qin SunBo Su
Jan 1, 2014·Vaccines·Benoît LevastSylvia van Drunen Littel-van den Hurk
Jan 30, 2010·Seminars in Immunopathology·Yinyao LinShabaana A Khader
Apr 22, 2011·Expert Review of Vaccines·Dennis ChristensenElse Marie Agger
Mar 19, 2011·Expert Opinion on Drug Delivery·Malou Henriksen-LaceyDennis Christensen
May 15, 2013·Current Opinion in Immunology·Pawan KumarJay K Kolls
Nov 10, 2009·Immunology Letters·Richard BrunnerIsabella Pali-Schöll
Jun 4, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Monique RichterDavid Singer
Aug 15, 2013·European Journal of Immunology·Yong Cheng, Jeffery S Schorey
Mar 25, 2015·International Immunopharmacology·Vera GeshevaAndrey Tchorbanov
Jun 12, 2009·Journal of Liposome Research·Dennis ChristensenYvonne Perrie
Oct 15, 2018·Journal of Cellular Physiology·Shima HadifarFarzam Vaziri
Jul 12, 2008·FEMS Microbiology Reviews·Nicole RitzNigel Curtis
Dec 17, 2009·FEMS Immunology and Medical Microbiology·Silvia A Moreno-MendietaRomina Rodriguez-Sanoja
Apr 27, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Isabelle C ArnoldAnne Müller
Feb 1, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susan L BaldwinRhea N Coler
Jan 28, 2017·Journal of Immunology Research·Valentina BernasconiNils Y Lycke
Jun 3, 2021·Pharmaceutics·Saed Abbasi, Satoshi Uchida
Jun 11, 2017·Vaccine·Ravendra GargVolker Gerdts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.